Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boni Elewski

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Journal of the American Academy of Dermatology|April 12, 2017
Efficacy of tofacitinib for the treatment of nail psoriasis: Two 52-week, randomized, controlled phase 3 studies in patients with moderate-to-severe plaque psoriasisJoseph F Merola, Boni Elewski, Svitlana Tatulych, et al.
Journal of the American Academy of Dermatology|February 21, 2006
Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trialGerald G Krueger, Boni Elewski, Kim Papp, et al.
Journal of Drugs in Dermatology : JDD|August 27, 2020
Nail Psoriasis Does Not Affect Skin Response to Ixekizumab in Patients With Moderate-To-Severe PsoriasisPhoebe Rich, Orin Goldblum, Damon Disch, et al.
Archives of Dermatology|November 23, 2011
A new classification system for grading the severity of onychomycosis: Onychomycosis Severity IndexCaitlin Carney, Antonella Tosti, Ralph Daniel, et al.
Journal of the American Podiatric Medical Association|April 11, 2023
Antifungal Activity of Efinaconazole Compared with Fluconazole, Itraconazole, and Terbinafine Against Terbinafine- and Itraconazole-Resistant/Susceptible Clinical Isolates of Dermatophytes, Candida, and MoldsAhmed Gamal, Mohammed Elshaer, Lisa Long, et al.
Skin Appendage Disorders|June 16, 2023
Hidradenitis Suppurativa and Five Key Vitamins and MineralsSydney Alexis Weir, Brittany Roman, Victoria Jiminez, et al.
Journal of Drugs in Dermatology : JDD|January 6, 2023
Sixty Years of Benzoyl Peroxide Use in DermatologyHilary Baldwin, Boni Elewski, Firas Hougeir, et al.
Mycoses|May 21, 2025
Efficacy and Safety of Efinaconazole 10% Topical Solution for Treatment of Onychomycosis in Older Adults: A Post Hoc Analysis of Two Phase 3 Randomised TrialsShari R Lipner, Aditya K Gupta, Warren S Joseph, et al.
Journal of the American Academy of Dermatology|January 9, 2007
Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgarisZoe D Draelos, Eric Carter, J Michael Maloney, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
Number of Affected Nails Is the Primary Determinant of Efinaconazole 10% Solution Usage for OnychomycosisSteven R Feldman, Tracey C Vlahovic, Warren S Joseph, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Journal of the American Academy of Dermatology|April 12, 2017
Efficacy of tofacitinib for the treatment of nail psoriasis: Two 52-week, randomized, controlled phase 3 studies in patients with moderate-to-severe plaque psoriasisJoseph F Merola, Boni Elewski, Svitlana Tatulych, et al.
Journal of the American Academy of Dermatology|February 21, 2006
Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trialGerald G Krueger, Boni Elewski, Kim Papp, et al.
Journal of Drugs in Dermatology : JDD|August 27, 2020
Nail Psoriasis Does Not Affect Skin Response to Ixekizumab in Patients With Moderate-To-Severe PsoriasisPhoebe Rich, Orin Goldblum, Damon Disch, et al.
Archives of Dermatology|November 23, 2011
A new classification system for grading the severity of onychomycosis: Onychomycosis Severity IndexCaitlin Carney, Antonella Tosti, Ralph Daniel, et al.
Journal of the American Podiatric Medical Association|April 11, 2023
Antifungal Activity of Efinaconazole Compared with Fluconazole, Itraconazole, and Terbinafine Against Terbinafine- and Itraconazole-Resistant/Susceptible Clinical Isolates of Dermatophytes, Candida, and MoldsAhmed Gamal, Mohammed Elshaer, Lisa Long, et al.
Skin Appendage Disorders|June 16, 2023
Hidradenitis Suppurativa and Five Key Vitamins and MineralsSydney Alexis Weir, Brittany Roman, Victoria Jiminez, et al.
Journal of Drugs in Dermatology : JDD|January 6, 2023
Sixty Years of Benzoyl Peroxide Use in DermatologyHilary Baldwin, Boni Elewski, Firas Hougeir, et al.
Mycoses|May 21, 2025
Efficacy and Safety of Efinaconazole 10% Topical Solution for Treatment of Onychomycosis in Older Adults: A Post Hoc Analysis of Two Phase 3 Randomised TrialsShari R Lipner, Aditya K Gupta, Warren S Joseph, et al.
Journal of the American Academy of Dermatology|January 9, 2007
Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgarisZoe D Draelos, Eric Carter, J Michael Maloney, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
Number of Affected Nails Is the Primary Determinant of Efinaconazole 10% Solution Usage for OnychomycosisSteven R Feldman, Tracey C Vlahovic, Warren S Joseph, et al.
Pageof 6